Professionnels de santé

Grand public

Presse
Ensemble, améliorons la qualité en santé

Home > Professionnels de santé > Actes - Médicaments - Dispositifs médicaux > Médicaments

Transparency Committee Opinion

ORENCIA

Date 18 July 2007
Pharmaceutical
formulation

ORENCIA 250 mg, powder for concentrate for solution for infusion
Box of 1 vial (CIP: 570 892-7)

ATC code
  1. L04AA24
Active ingredient

abatacept
Laboratory / Manufacturer BRISTOL-MYERS SQUIBB PHARMACEUTICALS
Reason for request Inclusion on the list of medicines approved for use by hospitals.

Documents

Tools

Contacts

Contact évaluation des médicaments

transparence@has-sante.fr


 

TAGS

Joint and rheumatic diseases - Autoimmune diseases - Drug therapy
Haute Autorité de Santé - 2009